Patients in Stamford, Greenwich, Fairfield County, and throughout Connecticut can schedule a medically supervised consultation to discuss GLP-1 therapy, semaglutide, tirzepatide, cardiometabolic risk, and long-term weight loss planning
We use GLP-1 in Cincinnati to treat: Excess fat in the stomach, thighs, buttocks, arms, and more High blood sugar Poor cardiac health Obesity A weight loss study followed up with 102 patients who were taking a GLP-1 medication after 6 months and found that: 89 (87.3%) achieved weight loss of 5% or more 56 (54.9%) achieved weight loss of 10% or more 24 (23.5%) achieved weight loss of 15% or more 8 (7.8%) achieved weight loss of 20% or more GLP-1 agonists are clearly effective for weight loss, transforming the bodies of many patients
Annual Ultherapy or Thermage on the lower face: $10,000 to $22,500 over five years
4 ~2/3 of lost weight regained within one year of stopping semaglutide A similar study tested deprescribing of tirzepatide (generic drug name for Zepbound)
This month, The Conversations experts explore their rise, impact and potential consequences
GulloFCerianiMD'AloiaAWankeEConstantiACostaBet al
